The term “life sciences” typically covers biotechnology, pharmaceuticals, medical devices, diagnostics, and increasingly the intersection of health care + technology (digital health, MedTech, genomics). Essentially: anything that uses biological science in service of human health. From an investor’s perspective, life sciences is interesting because: It speaks to large, long-term secular trends: aging populations, increasing chronic...Read More

The biotech sector in 2026 is offering one of the most dynamic investment landscapes we’ve seen in years. With scientific breakthroughs, regulatory changes, and technological convergence all aligning, this is a moment where strategic investors can capture outsized value. Below are the key forces to understand—and how they translate into actionable opportunities. 1. The Technology...Read More